John McBride

Insider Reports History

Location
C/O Tokai Pharmaceuticals, Inc., One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ Paul Little, as attorney-in-fact for John McBride
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John McBride:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Director Stock Option (right to buy) 30.9K $233K $1.55 Jan 10, 2025 Direct
Eledon Pharmaceuticals, Inc. Director Restricted Stock Units 3.43K Jan 10, 2025 Direct

Insider Reports Filed by John McBride

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELDN Eledon Pharmaceuticals, Inc. Jan 10, 2025 2 $0 4 Jan 13, 2025 Director
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Director